| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $17.5M | — | -23.3% |
| SG&A Expense | $4.1M | — | -42.3% |
| Operating Income | -$21.6M | — | +27.8% |
| Interest Expense | $23K | — | — |
| Pre-tax Income | -$20.2M | — | +28.2% |
| Income Tax | $0 | — | — |
| Net Income | -$20.2M | — | +28.2% |
| EPS (Basic) | -$1.88 | — | -506.5% |
| EPS (Diluted) | -$1.88 | — | -506.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $36.2M | -6.9% | +28.8% |
| Current Assets | $140.1M | -13.0% | -8.8% |
| Total Assets | $169.4M | -11.9% | -11.4% |
| Current Liabilities | $18.3M | -15.0% | +11.3% |
| Total Liabilities | $29.3M | -11.5% | -1.7% |
| Stockholders' Equity | $140.1M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$21.5M | — | +15.4% |
| Capital Expenditures | $37K | — | -97.5% |
| Investing Cash Flow | $18.9M | — | +759.9% |
| Financing Cash Flow | -$65K | — | +37.5% |
| Free Cash Flow | -$21.5M | — | +19.9% |
| -13.2% |